QuidelOrtho Corp

QDEL

29.100USD

+0.410+1.43%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

QuidelOrtho Corp's Score

Industry at a Glance

Industry Ranking

72 / 205

Overall Ranking

200 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

QuidelOrtho Corp Highlights

StrengthsRisks

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Fairly Valued

The company’s latest PE is -1.67, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 83.91M shares, decreasing 19.54% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 245.91K shares of this stock.

Analyst Rating

Based on 8 analysts

Hold

Current Rating

37.429

Target Price

+27.70%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of QuidelOrtho Corp is 5.76, ranking 187 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 699.90M, representing a year-over-year decrease of 3.74%, while its net profit experienced a year-over-year decrease of 3583.42%.

Score

Industry at a Glance

Previous score

5.76

Change

0



Financials

3.48

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.07

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.26

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.86

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

6.12

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of QuidelOrtho Corp is 8.38, ranking 23 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -1.67, which is -666.11% below the recent high of 9.47 and -29453.10% above the recent low of -494.25.

Score

Industry at a Glance

Previous score

8.38

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 72/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of QuidelOrtho Corp is 6.75, ranking 159 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 32.00, with a high of 60.00 and a low of 22.00.

Score

Industry at a Glance

Previous score

6.75

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of QuidelOrtho Corp is 6.96, ranking 65 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 34.51 and the support level at 24.75, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.91

Change

0.05

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of QuidelOrtho Corp is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 123.52%, representing a quarter-over-quarter increase of 5.62%. The largest institutional shareholder is The Vanguard, holding a total of 7.54M shares, representing 11.09% of shares outstanding, with 11.62% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

T. Rowe Price Investment Management, Inc.

11.01M

-1.11%

BlackRock Institutional Trust Company, N.A.

9.32M

+0.42%

The Vanguard Group, Inc.

Star Investors

7.60M

-2.13%

Rubric Capital Management LP

4.64M

--

Fidelity Management & Research Company LLC

4.44M

+73.81%

Dimensional Fund Advisors, L.P.

2.86M

+13.98%

Newtyn Management, LLC

2.70M

+58.30%

State Street Investment Management (US)

2.67M

-1.19%

Invesco Advisers, Inc.

2.66M

+100.02%

American Century Investment Management, Inc.

2.12M

+10.44%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of QuidelOrtho Corp is 4.84, ranking 95 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.71. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. QuidelOrtho Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

QuidelOrtho Corp

QDEL

6.92 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.61 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

8.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Becton Dickinson and Co

BDX

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

AxoGen Inc

AXGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Align Technology Inc

ALGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment